LINC 22: PRELUDE-BTK With Dr Lichtenberg: Serranator® PTA in Pts With PAD

Published: 08 Jun 2022

  • Views:

    Views Icon 80
  • Likes:

    Heart Icon 0

In this short interview, Dr Michael Lichtenberg (Vascular Centre Clinic Arnsberg, DE) joins us on-site at LINC 2022 to outline the findings of PRELUDE-BTK (NCT03693963). The study assessed the safety and efficacy of Cagent Vascular's Serranator® PTA balloon catheter (Cagent Vascular LLC) in patients with peripheral artery disease (PAD).

Discussion Points: 
1. Serranator® PTA Study Device
2. Reasoning For This Study
3. Inclusion/Exclusion Criteria and Study Design
4. Outcomes
5. Conclusions
6. Further Study Needed

Recorded onsite at LINC 2022, Leipzig.

Interviewer: Mirjam Boros
Editor: Jordan Rance
Videographer: Tom Green